{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T02:56:50Z","timestamp":1765421810741},"reference-count":43,"publisher":"Elsevier BV","issue":"34","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.vaccine.2011.05.099","type":"journal-article","created":{"date-parts":[[2011,6,24]],"date-time":"2011-06-24T09:28:10Z","timestamp":1308907690000},"page":"5740-5746","source":"Crossref","is-referenced-by-count":41,"title":["Invasive pneumococcal disease: Association between serotype, clinical presentation and lethality"],"prefix":"10.1016","volume":"29","author":[{"given":"M\u00aa Angeles Guti\u00e9rrez","family":"Rodr\u00edguez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amai Varela","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Ascensi\u00f3n Ordob\u00e1s","family":"Gav\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando Mart\u00edn","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natividad Garc\u00eda","family":"Mar\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bel\u00e9n Ramos","family":"Bl\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Carlos Sanz","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"42","key":"10.1016\/j.vaccine.2011.05.099_bib0005","first-page":"373","article-title":"23-Valent pneumococcal polysaccharide vaccine WHO position paper","volume":"83","author":"WHO","year":"2008","journal-title":"Wkly Epidemiol Rec"},{"issue":"9","key":"10.1016\/j.vaccine.2011.05.099_bib0010","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2807\/esm.11.09.00646-en","article-title":"Pneumococcal disease surveillance in Europe","volume":"11","author":"Pebody","year":"2006","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2011.05.099_bib0015","series-title":"Streptococcus pneumoniae Enfermedades infecciosas. Principios y pr\u00e1ctica. Mandell, Douglas y Bennett","author":"Musher","year":"2006"},{"key":"10.1016\/j.vaccine.2011.05.099_bib0020","doi-asserted-by":"crossref","first-page":"6406","DOI":"10.1016\/j.vaccine.2010.07.051","article-title":"First report of Streptococcus pneumoniae serotype 6D isolates from invasive infections","volume":"28","author":"Kuch","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.05.099_bib0025","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/S0140-6736(00)04222-7","article-title":"Geographical differences in invasive pneumococcal disease rates and serotype frequency in young children","volume":"357","author":"Hausdorff","year":"2001","journal-title":"The Lancet"},{"key":"10.1016\/j.vaccine.2011.05.099_bib0030","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1473-3099(05)01280-6","article-title":"Epidemiological differences among pneumococcal serotypes","volume":"5","author":"Hausdorff","year":"2005","journal-title":"Lancet Infect Dis"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2011.05.099_bib0035","first-page":"E071115.5","article-title":"Variation in incidence of pneumococcal and meningococcal disease across Europe","volume":"12","author":"Roberts","year":"2007","journal-title":"Euro Surveill"},{"issue":"1","key":"10.1016\/j.vaccine.2011.05.099_bib0040","first-page":"18","article-title":"Invasive pneumococcal disease in Australia, 2006","volume":"32","author":"Roche","year":"2008","journal-title":"Commun Dis Intell"},{"key":"10.1016\/j.vaccine.2011.05.099_bib0045","unstructured":"Center for Disease Control and Prevention. 2010. Active bacterial core surveillance (ABCs) report. Emerging infections program network, Streptococcus pneumoniae, provisional-2009. http:\/\/www.cdc.gov\/ncidod\/dbmd\/abcs\/survreports\/spneu09.pdf."},{"issue":"3","key":"10.1016\/j.vaccine.2011.05.099_bib0050","doi-asserted-by":"crossref","first-page":"e801","DOI":"10.1542\/peds.2005-3195","article-title":"Epidemiologic features of invasive pneumococcal disease in Belgian children: passive surveillance is not enough","volume":"118","author":"Vergison","year":"2006","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.vaccine.2011.05.099_bib0055","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1017\/S0950268806007199","article-title":"Burden of paediatric invasive pneumococcal disease in Europe, 2005","volume":"135","author":"McIntosh","year":"2007","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2011.05.099_bib0060","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jinf.2009.12.008","article-title":"Epidemiology of invasive pneumococcal disease in the pre-conjugate vaccine era: England and Wales 1996\u20132006","volume":"60","author":"Trotter","year":"2010","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2011.05.099_bib0065","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S1473-3099(06)70520-5","article-title":"Streptococcus pneumoniae in western Europe: serotype distribution and incidence in children less than 2 years old","volume":"6","author":"Jefferson","year":"2006","journal-title":"Lancet Infection Dis"},{"key":"10.1016\/j.vaccine.2011.05.099_bib0070","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s10096-007-0294-4","article-title":"Reduction in paediatric invasive pneumococcal disease in the Basque Country and Navarre, Spain, after the introduction of the heptavalent pneumococcal vaccine","volume":"26","author":"Aristegui","year":"2007","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2011.05.099_bib0075","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1016\/j.vaccine.2010.03.069","article-title":"Surveillance of invasive pneumococcal disease in 30 EU countries: towards a European system?","volume":"28","author":"Hanquet","year":"2010","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2011.05.099_bib0080","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1086\/516779","article-title":"Effectiveness of the 7-valent pneumococcal conjugate vaccine: a population-based case-control study","volume":"44","author":"Barricarte","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"26","key":"10.1016\/j.vaccine.2011.05.099_bib0085","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1016\/j.vaccine.2008.03.087","article-title":"Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway","volume":"26","author":"Vestrheim","year":"2008","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2011.05.099_bib0090","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1016\/j.vaccine.2006.11.032","article-title":"Immunogenicity, efficacy, safety and effectiveness of pneumococcal conjugate vaccines (1998\u20132006)","volume":"25","author":"Oosterhuis-Kafeja","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.05.099_bib0095","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1086\/648593","article-title":"Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine","volume":"201","author":"Pilishvili","year":"2010","journal-title":"JID"},{"key":"10.1016\/j.vaccine.2011.05.099_bib0100","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1016\/j.vaccine.2010.01.017","article-title":"Early effectiveness of heptavalent conjugate pneumococcal vaccination on invasive pneumococcal disease after the introduction in the Danish childhood immunization programme","volume":"28","author":"Harboe","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.05.099_bib0105","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1128\/JCM.01454-08","article-title":"Temporal trends of invasive Streptococcus pneumoniae serotypes and antimicrobial resistence patterns in Spain from 1979 to 2007","volume":"47","author":"Fenoll","year":"2009","journal-title":"J Clin Microbiol"},{"issue":"3","key":"10.1016\/j.vaccine.2011.05.099_bib0110","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1016\/j.ijid.2009.05.010","article-title":"Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines","volume":"14","author":"Isaacman","year":"2010","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.05.099_bib0115","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1086\/591128","article-title":"Large community outbreak of Streptococcus pneumoniae serotype 5 invasive infection in an impoverished, urban population","volume":"47","author":"Romney","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"9568","key":"10.1016\/j.vaccine.2011.05.099_bib0120","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0140-6736(07)60564-9","article-title":"Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis","volume":"369","author":"Grijalva","year":"2007","journal-title":"Lancet"},{"issue":"18","key":"10.1016\/j.vaccine.2011.05.099_bib0125","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa022823","article-title":"Decline in invasive pneumococcal disease after the introduction of protein\u2013polysaccharide conjugate vaccine","volume":"348","author":"Whitney","year":"2003","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.vaccine.2011.05.099_bib0130","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1086\/524660","article-title":"Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine","volume":"46","author":"Mu\u00f1oz-Almagro","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2011.05.099_bib0135","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1086\/521626","article-title":"Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998\u20132004","volume":"196","author":"Hicks","year":"2007","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2011.05.099_bib0140","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1086\/430604","article-title":"Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups","volume":"41","author":"Byington","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"3 Pt 1","key":"10.1016\/j.vaccine.2011.05.099_bib0145","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1542\/peds.113.3.443","article-title":"Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine","volume":"113","author":"Kaplan","year":"2004","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.vaccine.2011.05.099_bib0150","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1542\/peds.2008-1702","article-title":"Serotype 19A is the most common serotype causing invasive pneumococcal infections in children","volume":"125","author":"Kaplan","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2011.05.099_bib0155","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1086\/655828","article-title":"Association of serotype with risk of death due a pneumococcal pneumoniae: a meta-analysis","volume":"51","author":"Weinberger","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2011.05.099_bib0160","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1086\/499242","article-title":"Clonal and capsular types decide whether pneumococci will act as a primary or opportunistic pathogen","volume":"42","author":"Sj\u00f6str\u00f6m","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2011.05.099_bib0165","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-2334-4-21","article-title":"Serotype-specific mortality from invasive Streptococcus pneumoniae disease revisited","volume":"4","author":"Martens","year":"2004","journal-title":"BMC Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2011.05.099_bib0170","doi-asserted-by":"crossref","first-page":"e1000081","DOI":"10.1371\/journal.pmed.1000081","article-title":"Pneumococcal serotypes and mortality following invasive pneumococcal disease: a population-based cohort study","volume":"6","author":"Harboe","year":"2009","journal-title":"PLoS Med"},{"issue":"July (2)","key":"10.1016\/j.vaccine.2011.05.099_bib0175","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1086\/600045","article-title":"Invasive pneumococcal disease among adults: associations among serotypes, disease characteristics, and outcome","volume":"49","author":"Jansen","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2011.05.099_bib0180","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1183\/09031936.00041210","article-title":"The paradox in pneumococcal serotypes: highly invasive does not mean highly lethal","volume":"36","author":"Pletz","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.vaccine.2011.05.099_bib0185","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1086\/315761","article-title":"Molecular epidemiology of Streptococcus pneumoniae causing invasive disease in 5 countries","volume":"182","author":"Henriques","year":"2000","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2011.05.099_bib0190","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1128\/CVI.00317-10","article-title":"Relationship between serotypes, age, and clinical presentation of Invasive pneumococcal Disease in Madrid, Spain, after introduction of 7-valent pneumococcal conjugate vaccine into the vaccination calendar","volume":"18","author":"Picazo","year":"2011","journal-title":"Clin Vaccine Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2011.05.099_bib0195","doi-asserted-by":"crossref","first-page":"5387","DOI":"10.1128\/AAC.00217-10","article-title":"Serotype distribution and susceptibility of Streptococcus pneumoniae isolates from pleural fluid in Spain from 1997 to 2008","volume":"54","author":"Fenoll","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.vaccine.2011.05.099_bib0200","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.3201\/eid1409.071094","article-title":"Pediatric parapneumonic empyema, Spain","volume":"14","author":"Obando","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2011.05.099_bib0205","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1001\/jama.295.14.1668","article-title":"Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine","volume":"295","author":"Phoeling","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2011.05.099_bib0210","doi-asserted-by":"crossref","first-page":"5166","DOI":"10.1016\/j.vaccine.2010.06.008","article-title":"Serotypes 1, 7F, and 19A became the leading causes of pediatric invasive pneumococcal infections in Portugal after 7 years of heptavalent conjugate vaccine use","volume":"28","author":"Aguiar","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.05.099_bib0215","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.1016\/j.vaccine.2010.04.020","article-title":"Pneumococcal disease caused by serotype 19A: review of the literature and implications for future vaccine development","volume":"28","author":"Reinert","year":"2010","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11008656?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11008656?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T05:50:59Z","timestamp":1560318659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11008656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":43,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S0264410X11008656"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.05.099","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}